Evaluation of CD52 positive sperms in subfertile human semen samples: Is there any relationship with main semen parameters?

Aboutorabi, Roshanak; Mazani, Fatemeh; Rafiee, Laleh

Evaluation of CD52 positive sperms in subfertile human semen samples: Is there any relationship with main semen parameters?

Authors

¹ Head of Infertility Laboratory, Shahid Beheshti Hospital; Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Physiology, School of Medicine, Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Sperm maturation and sperm membrane integration are the most important elements in male fertility. CD52 is one of the antigens. CD52 is a GPI (glycosylphosphatidylinositol) anchored that express on lymphocytes and epididymal cells. This antigen bind to sperm membrane during transition sperm from epididymal duct as well as its relationship with semenogelins in human seminal plasma. The aim of this study was to obtain any association between the percentage of CD52 positive sperms with main semen parameters such as percentage of motile sperms, percentage of sperm with normal morphology, and the presence of normal viscosity.
Materials and Methods: Semen samples from subfertile men were analyzed, the samples totally were 45 that divided according to their motility into three groups, first one, more than 40%, second one 10-40%, and the third one under 10% total motility. Fifteen samples in each group were evaluated by semen analysis according to WHO 2010 guidelines for infertility laboratory. Sperms were washed by Ham's F-10 and immunostaining with the monoclonal antibody CAMPATH-1G and then analyzed by flow cytometry. We compared each of the groups based on their motility and the data were analyzed by SPSS 20.
Results: Correlation between CD52 labeling and sperm motility was negatively significant, in the second group (r = -0.592, P = 0.020) and in the third group (r = -0.805, P = 0.00).
Conclusion: Our results showed that the correlation between CD52 labeling and sperm motility was negatively significant, but we did not observe any relation with other semen parameters, such as sperm normal morphology, sperm concentration, and semen viscosity.

Keywords

References

1.	Hwang K, Walters RC, Lipshultz LI. Contemporary concepts in the evaluation and management of male infertility. Nat Rev Urol 2011;8:86-94.
2.	Sullivan R. Male fertility markers, myth or reality. Anim Reprod Sci 2004;82:341-7. [PUBMED]
3.	Elia J, Imbrogno N, Delfino M, Mazzilli R, Rossi T, Mazzilli F. The importance of the sperm motility classes-Future directions. Open Androl J 2010;2:42-3.
4.	Eliasson R. Semen analysis with regard to sperm number, sperm morphology and functional aspects. Asian J Androl 2010;12:26-32.
5.	Menkveld R. Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen. Asian J Androl 2010;12:47-58.
6.	Anerao AM, Sharma RC, Rathore M, Gangawane AK. Studies on human sperm motility and viability when treatment with rock salt (Saindhav). J Pathol Res 2010;1:1-10.
7.	Sullivan R, Saez F, Girouard J, Frenette G. Role of exosomes in sperm maturation during the transit along the male reproductive tract. Blood Cells Mol Dis 2005;35:1-10.
8.	Elzanaty S, Richthoff J, Malm J, Giwercman A. The impact of epididymal and accessory sex gland function on sperm motility. Hum Reprod 2002;17:2904-11.
9.	Yeung CH, Schröter S, Wagenfeld A, Kirchhoff C, Kliesch S, Poser D, et al. Interaction of the human epididymal protein CD52 (HE5) with epididymal spermatozoa from men and cynomolgus monkeys. Mol Reprod Dev 1997;48:267-75.
10.	Yamaguchi R, Yamagata K, Hasuwa H, Inano E, Ikawa M, Okabe M. Cd52, known as a major maturation-associated sperm membrane antigen secreted from the epididymis, is not required for fertilization in the mouse. Genes Cells 2008;13:851-61.
11.	Kirchhoff C. CD52 is the ′major maturation-associated′ sperm membrane antigen. Mol Hum Reprod 1996;2:9-17. [PUBMED]
12.	Tone M, Nolan KF, Walsh LA, Tone Y, Thompson SA, Waldmann H. Structure and chromosomal location of mouse and human CD52 genes. Biochim Biophys Acta 1999;1446:334-40.
13.	Ettenger R, Yadin O. The potential role of therapeutic antibodies in the regulation of rejection. In Transplantation proceedings, Elsevier; 1995.
14.	Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, et al. Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders. Med Oncol 2001;18:99-107.
15.	Nicolás M. Ortega and Pablo Bosch (2012). Methods for Sperm Selection for In Vitro Fertilization, In Vitro Fertilization-Innovative Clinical and Laboratory Aspects, Prof. Shevach Friedler ISBN: 978-953-51-0503-9, InTech, Available from: http://www.intechopen.com/books/...-for-in-vitro-fertilization [Last accessed on 2013 Apr 17].
16.	Schröter S, Derr P, Conradt HS, Nimtz M, Hale G, Kirchhoff C. Male-specific modification of human CD52. J Biol Chem 1999;274:29862-73.
17.	Flori F, Ermini L, La Sala GB, Nicoli A, Capone A, Focarelli R, et al. The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen. Mol Reprod Dev 2008;75:326-35.
18.	Terai K, Yoshida K, Yoshiike M, Fujime M, Iwamoto T. Association of seminal plasma motility inhibitors/semenogelins with sperm in asthenozoospermia-infertile men. Urol Int 2010;85:209-15.
19.	Lilja H, Oldbring J, Rannevik G, Laurell CB. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 1987;80:281-5. [PUBMED]
20.	de Lamirande E, Yoshida K, Yoshiike TM, Iwamoto T, Gagnon C. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. J Androl 2001;22:672-9.
21.	Sullivan R, Frenette G, Girouard J. Epididymosomes are involved in the acquisition of new sperm proteins during epididymal transit. Asian J Androl 2007;9:483-91.
22.	Yeung CH, Cooper TG, Nieschlag E. Human epididymal secreted protein CD52 on ejaculated spermatozoa: Correlations with semen characteristics and the effect of its antibody. Mol Hum Reprod 1997;3:1045-51.
23.	Yoshida K, Krasznai ZT, Krasznai Z, Yoshiike M, Kawano N, Yoshida M, et al. Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans. Cell Motil Cytoskeleton 2009;66:99-108.
24.	Yeung CH, Pérez-Sánchez F, Schröter S, Kirchhoff C, Cooper TG. Changes of the major sperm maturation-associated epididymal protein HE5 (CD52) on human ejaculated spermatozoa during incubation in capacitation conditions. Mol Hum Reprod 2001;7:617-24.
25.	Ainsworth C, Nixon B, Aitken RJ. Development of a novel electrophoretic system for the isolation of human spermatozoa. Hum Reprod 2005;20:2261-70.
26.	Ainsworth CJ, Nixon B, Aitken RJ. The electrophoretic separation of spermatozoa: An analysis of genotype, surface carbohydrate composition and potential for capacitation. Int J Androl 2011;34:e422-34.
27.	Giuliani V, Pandolfi C, Santucci R, Pelliccione F, Macerola B, Focarelli R, et al. Expression of gp20, a human sperm antigen of epididymal origin, is reduced in spermatozoa from subfertile men. Mol Reprod Dev 2004;69:235-40.
28.	Said TM, Land JA. Effects of advanced selection methods on sperm quality and ART outcome: A systematic review. Hum Reprod Update 2011;17:719-33.
29.	Yeung CH, Cooper TG, Schröter S, Kirchhoff C, Nieschlag E. Epididymal secretion of CD52 as measured in human seminal plasma by a fluorescence immunoassay. Mol Hum Reprod 1998;4:447-51.

Advanced Biomedical Research